Cargando…

Short-term clinical effects of robot-assisted esophagectomy with thoracic duct resection

BACKGROUND: Whether extended robot-assisted esophagectomy with thoracic duct resection (RAE-TDR) has a favorable effect on esophageal cancer patients is not yet known. This study sought to analyze the safety and efficiency of RAE-TDR. METHODS: From January 2019 to July 2020, 73 thoracic duct (TD)-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chunguang, Li, Bin, Yang, Yang, Li, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007922/
https://www.ncbi.nlm.nih.gov/pubmed/36915429
http://dx.doi.org/10.21037/jgo-22-985
_version_ 1784905638231408640
author Li, Chunguang
Li, Bin
Yang, Yang
Li, Zhigang
author_facet Li, Chunguang
Li, Bin
Yang, Yang
Li, Zhigang
author_sort Li, Chunguang
collection PubMed
description BACKGROUND: Whether extended robot-assisted esophagectomy with thoracic duct resection (RAE-TDR) has a favorable effect on esophageal cancer patients is not yet known. This study sought to analyze the safety and efficiency of RAE-TDR. METHODS: From January 2019 to July 2020, 73 thoracic duct (TD)-resected and 127 TD-preserved consecutive patients who received standard RAE McKeown surgery were enrolled in this study. The perioperative-related indicators of recurrence-free survival (RFS) and overall survival (OS) at 1-year were compared between the 2 groups. RESULTS: In relation to morbidity, the Clavien–Dindo (CD) classifications for grades greater than or equal to II–III were similar between the 2 groups (P>0.05). The number of retrieved total lymph nodes (LNs) and mediastinal nodes were significantly higher in the TD-resected group than in the TD-preserved group (total lymph nodes: 29.0±11.1 vs. 25.1±8.5, P=0.006; mediastinal nodes: 19.5±8.0 vs. 16.1±5.5, P=0.002). Additionally, more metastatic TD-related LNs were harvested in cT3–4 patients (2.3±3.7 vs. 1.7±2.8; P=0.21). The rates of LN recurrence and local recurrence were similar between the 2 groups (LN recurrence: 6.8% vs. 7.1%, P>0.99; local recurrence: 1.4% vs. 2.4%, P>0.99). The OS and RFS at 1-year were equivalent regardless of the TD procedure at each stage (P>0.05). However, the rate of hematogenous metastasis in the TD-resected group was significantly elevated (17.8% vs. 7.9%; P=0.034). CONCLUSIONS: RAE-TDR may help to improve total and metastatic LN harvest, especially in patients with advanced esophageal squamous cell carcinoma (ESCC) without increasing the intra- and post-operative adverse events. However, RAE-TDR did not lead to a decrease in the local recurrence rate within the short-term follow-up period. Whether the increase in distant metastasis rate in the TD-resected group was associated with relevant immune system damage is unclear. Thus, nonselective RAE-TDR is not routinely recommended.
format Online
Article
Text
id pubmed-10007922
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-100079222023-03-12 Short-term clinical effects of robot-assisted esophagectomy with thoracic duct resection Li, Chunguang Li, Bin Yang, Yang Li, Zhigang J Gastrointest Oncol Original Article BACKGROUND: Whether extended robot-assisted esophagectomy with thoracic duct resection (RAE-TDR) has a favorable effect on esophageal cancer patients is not yet known. This study sought to analyze the safety and efficiency of RAE-TDR. METHODS: From January 2019 to July 2020, 73 thoracic duct (TD)-resected and 127 TD-preserved consecutive patients who received standard RAE McKeown surgery were enrolled in this study. The perioperative-related indicators of recurrence-free survival (RFS) and overall survival (OS) at 1-year were compared between the 2 groups. RESULTS: In relation to morbidity, the Clavien–Dindo (CD) classifications for grades greater than or equal to II–III were similar between the 2 groups (P>0.05). The number of retrieved total lymph nodes (LNs) and mediastinal nodes were significantly higher in the TD-resected group than in the TD-preserved group (total lymph nodes: 29.0±11.1 vs. 25.1±8.5, P=0.006; mediastinal nodes: 19.5±8.0 vs. 16.1±5.5, P=0.002). Additionally, more metastatic TD-related LNs were harvested in cT3–4 patients (2.3±3.7 vs. 1.7±2.8; P=0.21). The rates of LN recurrence and local recurrence were similar between the 2 groups (LN recurrence: 6.8% vs. 7.1%, P>0.99; local recurrence: 1.4% vs. 2.4%, P>0.99). The OS and RFS at 1-year were equivalent regardless of the TD procedure at each stage (P>0.05). However, the rate of hematogenous metastasis in the TD-resected group was significantly elevated (17.8% vs. 7.9%; P=0.034). CONCLUSIONS: RAE-TDR may help to improve total and metastatic LN harvest, especially in patients with advanced esophageal squamous cell carcinoma (ESCC) without increasing the intra- and post-operative adverse events. However, RAE-TDR did not lead to a decrease in the local recurrence rate within the short-term follow-up period. Whether the increase in distant metastasis rate in the TD-resected group was associated with relevant immune system damage is unclear. Thus, nonselective RAE-TDR is not routinely recommended. AME Publishing Company 2023-02-21 2023-02-28 /pmc/articles/PMC10007922/ /pubmed/36915429 http://dx.doi.org/10.21037/jgo-22-985 Text en 2023 Journal of Gastrointestinal Oncology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Li, Chunguang
Li, Bin
Yang, Yang
Li, Zhigang
Short-term clinical effects of robot-assisted esophagectomy with thoracic duct resection
title Short-term clinical effects of robot-assisted esophagectomy with thoracic duct resection
title_full Short-term clinical effects of robot-assisted esophagectomy with thoracic duct resection
title_fullStr Short-term clinical effects of robot-assisted esophagectomy with thoracic duct resection
title_full_unstemmed Short-term clinical effects of robot-assisted esophagectomy with thoracic duct resection
title_short Short-term clinical effects of robot-assisted esophagectomy with thoracic duct resection
title_sort short-term clinical effects of robot-assisted esophagectomy with thoracic duct resection
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007922/
https://www.ncbi.nlm.nih.gov/pubmed/36915429
http://dx.doi.org/10.21037/jgo-22-985
work_keys_str_mv AT lichunguang shorttermclinicaleffectsofrobotassistedesophagectomywiththoracicductresection
AT libin shorttermclinicaleffectsofrobotassistedesophagectomywiththoracicductresection
AT yangyang shorttermclinicaleffectsofrobotassistedesophagectomywiththoracicductresection
AT lizhigang shorttermclinicaleffectsofrobotassistedesophagectomywiththoracicductresection